VCNX

$0.71+1.14%visit website

VACCINEX, INC.

Market Cap

$2M

Live price × Finnhub shares (2026-09-24)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.74

60mo monthly vs SPY

P/E (TTM)

—

No recent SEC filing data

No 10-Q/10-K since Apr 15, 2025

P/S (TTM)

—

No recent SEC filing data

No 10-Q/10-K since Apr 15, 2025

P/B

—

No recent SEC filing data

No 10-Q/10-K since Apr 15, 2025

EV/EBITDA (TTM)

—

No recent SEC filing data

No 10-Q/10-K since Apr 15, 2025

Loading…

Financial Statements

USD thousands	Q1 FY2024 Mar 31, 2024	Q2 FY2024 Jun 30, 2024	Q3 FY2024 Sep 30, 2024	Q4 FY2024 Dec 31, 2024	TTM Dec 31, 2024
Revenue	104	232	52	213	601
Research & development	3,383	3,864	3,165	2,133	12,545
Operating income	(5,074)	(5,722)	(4,552)	(3,387)	(18,735)
Interest expense					2.00
Pretax income	(3,897)	(5,631)	(5,732)	(3,374)	(18,634)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(3,897)	(5,631)	(5,732)	(3,374)	(18,634)
EPS (basic) ($)	(2.35)	(3.10)	(2.83)		(8.88)
EPS (diluted) ($)	(2.35)	(3.10)	(2.83)		(8.88)
Weighted avg. shares (basic)	1,659	1,818	2,027
Weighted avg. shares (diluted)	1,659	1,818	2,027

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-K filed Apr 15, 2025, period ended Dec 31, 2024. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 27 more quarters, back to Jun 2017, with Tormere Pro.

Corporate Events (8-K)

0 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Mar 19, 2025 accepted 12:15 PM ET	5.02Officer / director change	Document SEC ↗
Mar 7, 2025 accepted 12:21 PM ET	3.01Delisting notice7.01Reg FD disclosure	Document SEC ↗
Dec 17, 2024 accepted 4:32 AM ET	3.01Delisting notice8.01Other events	Document SEC ↗
Nov 14, 2024 accepted 12:00 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗